IG 278 Pill - white round, 6mm
Pill with imprint IG 278 is White, Round and has been identified as Topiramate 25 mg. It is supplied by InvaGen Pharmaceuticals, Inc.
Topiramate is used in the treatment of Migraine Prevention; Lennox-Gastaut Syndrome; Seizure Prevention; Epilepsy; Seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for IG 278
Topiramate
- Imprint
- IG 278
- Strength
- 25 mg
- Color
- White
- Size
- 6.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- InvaGen Pharmaceuticals, Inc.
- Inactive Ingredients
-
lactose monohydrate,
microcrystalline cellulose,
corn starch,
sodium starch glycolate type A potato,
magnesium stearate,
silicon dioxide,
hypromellose 2910 (3 mPa.s),
hypromellose 2910 (6 mPa.s),
polyethylene glycol 400,
polysorbate 80
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
31722-0278 | Camber Pharmaceuticals, Inc. |
60429-0769 (Discontinued) | Golden State Medical Supply (repackager) |
Related images for "IG 278"
More about topiramate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,327)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- Breastfeeding
Patient resources
- Topiramate drug information
- Topiramate Extended-Release Capsules
- Topiramate Extended-Release Sprinkle Capsules
- Topiramate Sprinkle Capsules
Other brands
Topamax, Trokendi XR, Eprontia, Topiragen, Qudexy XR
Professional resources
Other brands
Topamax, Trokendi XR, Eprontia, Qudexy XR
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.